(Q46990341)

English

Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

1 reference

based on heuristic

inferred from title

paraneoplastic syndrome

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

Stella M. Ranuncolo

6

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Leandro Cerchietti

object named as

Leandro Carlos Cerchietti

4

0 references

author name string

Miriam Judith Diament

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Guillermo Daniel Peluffo

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Isabel Stillitani

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Alfredo Navigante

5

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Slobodanka Mariana Klein

7

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

24

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

126-131

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Biology of cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

The metabolic basis of cancer cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Progestin suppresses matrix metalloproteinase production in endometrial cancer

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Cytokines and Their Role in the Pathophysiology of Cancer Cachexia

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Interleukin-1--a major pleiotropic cytokine in tumor-host interactions

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

The production of cytokines by polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524322

21 January 2018

Identifiers

10.1080/07357900500524322

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16537180

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46990341&oldid=2141004402"